Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. Packer M, Anker SD, Butler J, Filippatos G, et al. N Engl J Med 2020 Aug 29. doi: 10.1056/NEJMoa2022190.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Packer M, Anker SD, Butler J, Filippatos G, et al. Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure. N Engl J Med 2020 Aug 29. doi: 10.1056/NEJMoa2022190.
PMID: 32865377